<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Toxic Dolls | Willis Dickens | Activity</title>
	<link>https://toxicdolls.com/members/quailalley7/activity/</link>
	<atom:link href="https://toxicdolls.com/members/quailalley7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Willis Dickens.</description>
	<lastBuildDate>Mon, 04 May 2026 16:22:51 +0000</lastBuildDate>
	<generator>https://buddypress.org/?v=</generator>
	<language>en-US</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">bf1d1acc2371ef79751cb07c72cff24a</guid>
				<title>Willis Dickens posted an update: Three-dimensional (3D) printing technologies are based on [&#133;]</title>
				<link>https://toxicdolls.com/activity-2/p/8975/</link>
				<pubDate>Mon, 23 Jun 2025 18:47:32 +0000</pubDate>

									<content:encoded><![CDATA[<p>Three-dimensional (3D) printing technologies are based on successive material printing layer-by-layer and are considered suitable for the production of dosage forms customized for a patient&#8217;s needs. In this study, tablets of atomoxetine hydrochloride (ATH) have been successfully fabricated by a digital light processing (DLP) 3D printing&hellip;<span class="activity-read-more" id="activity-read-more-8975"><a href="https://toxicdolls.com/activity-2/p/8975/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">cec47ccc4ab01905d1a0582fd9db6290</guid>
				<title>Willis Dickens became a registered member</title>
				<link>https://toxicdolls.com/activity-2/p/8901/</link>
				<pubDate>Mon, 23 Jun 2025 18:15:16 +0000</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>